These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11532686)

  • 21. [Cardiovascular disease in Chinese chronic renal insufficiency patients-epidemiology survey].
    Hou FF; Ma ZG; Mei CL; Rong S; Huang SM; Liu XR; Yuan WJ; Guo YS; Wang L; He Q; Wang XL; Sang XH; Li XL
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):458-63. PubMed ID: 15854551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The Göttingen Risk, Incidence and Prevalence (GRIPS) study. Recommendations for the prevention of coronary heart disease].
    Cremer P; Muche R
    Ther Umsch; 1990 Jun; 47(6):482-91. PubMed ID: 2375005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of cardiovascular risk factors in chronic renal disease.
    Coresh J; Longenecker JC; Miller ER; Young HJ; Klag MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S24-30. PubMed ID: 11443765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
    Pernod G; Bosson JL; Golshayan D; Barro C; Alloatti S; Turc-Baron C; Quarello F; Jeantet A; Von Albertini B; Forêt M; Lauren G; Cordonnier D; Piccoli G; Wauters JP;
    J Nephrol; 2004; 17(1):66-75. PubMed ID: 15151261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between left ventricular hypertrophy with retinopathy and renal dysfunction in patients with essential hypertension.
    Shirafkan A; Motahari M; Mojerlou M; Rezghi Z; Behnampour N; Gholamrezanezhad A
    Singapore Med J; 2009 Dec; 50(12):1177-83. PubMed ID: 20087555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.
    Parikh NI; Hwang SJ; Larson MG; Meigs JB; Levy D; Fox CS
    Arch Intern Med; 2006 Sep; 166(17):1884-91. PubMed ID: 17000946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
    Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
    Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine increases the risk associated with hyperlipidaemia.
    Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of anemia, secondary hyperparathyroidism with left ventricular hypertrophy in Chronic Kidney Disease patients.
    Datta S; Abraham G; Mathew M; Somasundaram H; Muralidharan TR; Moorthy A; Sathyasekaran ; Leslie N
    J Assoc Physicians India; 2006 Sep; 54():699-703. PubMed ID: 17212016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutrition-related cardiovascular risk factors in hemodialysis patients.
    Arslan Y; Kiziltan G
    J Ren Nutr; 2010 May; 20(3):185-92. PubMed ID: 19819725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular geometry in children with mild to moderate chronic renal insufficiency.
    Matteucci MC; Wühl E; Picca S; Mastrostefano A; Rinelli G; Romano C; Rizzoni G; Mehls O; de Simone G; Schaefer F;
    J Am Soc Nephrol; 2006 Jan; 17(1):218-26. PubMed ID: 16280471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Improvement of left ventricular hypertrophy by anemic-correcting erythropoietin therapy in chronic renal insufficiency].
    Jiang JP; Hou FF; Gao LZ; Pan YB; Yang NS; Chen W; Shu GY; Chen YM; Chen J; Peng WH; Wu JP; Yang ZM
    Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):25-9. PubMed ID: 15769393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anemia: an early complication of chronic renal insufficiency.
    Kazmi WH; Kausz AT; Khan S; Abichandani R; Ruthazer R; Obrador GT; Pereira BJ
    Am J Kidney Dis; 2001 Oct; 38(4):803-12. PubMed ID: 11576884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status.
    Norata GD; Baragetti I; Raselli S; Stucchi A; Garlaschelli K; Vettoretti S; Piloni G; Buccianti G; Catapano AL
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):56-63. PubMed ID: 19359150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Left ventricular hypertrophy in predialysis chronic kidney disease: impact of cardiomuscular stress markers].
    Kimura T; Iio K; Obi Y; Hayashi T
    Nihon Jinzo Gakkai Shi; 2007; 49(8):1007-13. PubMed ID: 18186229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.